LOXL1, THY1, and TYMS define an annotation-derived hemoglobin-associated immunotranscriptomic signature in osteoarthritis cartilage
-
By
-
Xin Zhang
-
Zhaochen Ye
-
Zheng Qin
-
Yizhe Li
-
Zhilong Jing
-
Dawei Yang
-
July 9, 2026
-
Clinical Scorecard: An Immunotranscriptomic Signature Linked to Hemoglobin in Osteoarthritis Cartilage Identified by LOXL1, THY1, and TYMS Markers
At a Glance
| Category | Detail |
|---|
| Condition | Osteoarthritis (OA) |
| Key Mechanisms | Hemoglobin-associated transcriptional programs and immune-related transcriptomic features |
| Target Population | Individuals with osteoarthritis |
| Care Setting | Research and clinical diagnostics |
Key Highlights
- Identification of LOXL1, THY1, and TYMS as Hb-associated biomarkers in OA cartilage.
- High discriminative performance of a nomogram based on these biomarkers (AUC of 0.974).
- Association of Hb-associated genes with macrophage and activated T-cell signatures.
Guideline-Based Recommendations
Diagnosis
- Use of Hb-associated biomarkers for potential diagnostic applications in OA.
Management
- Consideration of immune profiling in OA management strategies.
Monitoring & Follow-up
- Monitoring of Hb-associated gene expression as a potential indicator of disease progression.
Risks
- Increased immune activation may contribute to cartilage degeneration.
Patient & Prescribing Data
Patients diagnosed with osteoarthritis.
Potential for targeting immune pathways in OA treatment.
Clinical Best Practices
- Integrate transcriptomic analysis in OA research.
- Utilize machine-learning approaches for biomarker identification.
Related Resources & Content
